Exercise or conversion by Brett Sandercock of 5000 shares of ResMed subject to Rule 16b-3
ResMed Inc insider trading alert for exercise of resmed nq stock options by Brett Sandercock, Chief Financial Officer, on December 23, 2017. This event was filed by Resmed Inc with SEC on 2013-08-29. Statement of changes in beneficial ownership - SEC Form 4. Brett Sandercock is currently serves as cfo and principal accounting officer of ResMed Inc
Filed transaction by Resmed Inc officer. Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
Story MomentumThis story impact on price volatility cannot be determined at this time. Please check this story after some time to allow current data to be analyzed.
Similar stores for ResMed